Pyoderma
Showing 1 - 25 of 236
Pyoderma Gangrenosum Trial in New York (Spesolimab)
Recruiting
- Pyoderma Gangrenosum
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Oct 16, 2023
Pyoderma Gangrenosum Trial (Platelet rich plasma therapy)
Not yet recruiting
- Pyoderma Gangrenosum
- Platelet rich plasma therapy
- (no location specified)
Aug 2, 2023
Pyoderma Gangrenosum Trial in Lebanon (Deucravacitinib)
Not yet recruiting
- Pyoderma Gangrenosum
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Apr 6, 2023
Pyoderma, Pyoderma Gangrenosum, Pyoderma Vegetans Trial in Minsk, Riga (Monoclonal antibody (Mab) sB24M)
Active, not recruiting
- Pyoderma
- +3 more
- Monoclonal antibody (Mab) sB24M
-
Minsk, Belarus
- +1 more
Jul 8, 2022
Pyoderma Gangrenosum Trial (Hyperbaric oxygen, Control group)
Not yet recruiting
- Pyoderma Gangrenosum
- Hyperbaric oxygen
- Control group
- (no location specified)
Jul 14, 2022
Pyoderma Gangrenosum Trial in Gahanna (Ixekizumab)
Completed
- Pyoderma Gangrenosum
- Ixekizumab
-
Gahanna, OhioThe Ohio State University Dermatology
May 11, 2022
JAK-STAT Signaling Pathway in Pyoderma Gangrenosum
Not yet recruiting
- Pyoderma Gangrenosum
- +2 more
- immunohistochemical methods
- (no location specified)
Mar 21, 2022
Pyoderma Trial in Russian Federation (Hydroxymethylquinoxalindioxyde, Benzyl-dimethyl-[3-(tetradecanoylamino)propyl]azanium)
Recruiting
- Pyoderma
-
Chelyabinsk, Russian Federation
- +9 more
Sep 27, 2022
Pyoderma Gangrenosum Trial in Metairie, New Orleans (Dehydrated human amnion/chorion membrane)
Recruiting
- Pyoderma Gangrenosum
- Dehydrated human amnion/chorion membrane
-
Metairie, Louisiana
- +2 more
Nov 9, 2021
Pyoderma Gangrenosum, Skin Diseases, Wound Heal Trial in Portland (Baricitinib)
Recruiting
- Pyoderma Gangrenosum
- +4 more
-
Portland, OregonOregon Health and Science University
Sep 8, 2021
Pyoderma Gangrenosum Trial (secukinumab 150 mg (2 injections per dose)
Withdrawn
- Pyoderma Gangrenosum
- secukinumab 150 mg (2 injections per dose
- (no location specified)
May 25, 2021
Disease State in Adult Participants Being Treated With Humira in
Recruiting
- Pyoderma Gangrenosum
-
Nagoya shi, Aichi, Japan
- +44 more
Jan 13, 2023
Pyoderma Gangrenosum Trial in Tallahassee (Xilonix)
Completed
- Pyoderma Gangrenosum
- Xilonix
-
Tallahassee, FloridaXBiotech Investigative Site
Jan 26, 2021
Pyoderma Gangrenosum Trial in Munich (Secukinumab)
Unknown status
- Pyoderma Gangrenosum
-
Munich, GermanyTechnical University of Munich
Feb 17, 2020
Pyoderma Gangrenosum Trial in Winston-Salem (adalimumab)
Withdrawn
- Pyoderma Gangrenosum
-
Winston-Salem, North CarolinaWake Forest University Health Sciences Dermatology
Dec 17, 2019
Chronic Ulcer of Skin Trial in Tampere (Thermal imaging in diagnostics of chronic ulcers)
Enrolling by invitation
- Chronic Ulcer of Skin
- Thermal imaging in diagnostics of chronic ulcers
-
Tampere, FinlandTampere University Hospital
Jul 3, 2023
Streptococcus Pyogenes Carriage Acquisition and Transmission
Completed
- Group A Streptococcal Infection
- +2 more
-
Fajara, GambiaMRC Unit The Gambia at LSHTM
Nov 21, 2022
Inflammatory Marker in Ibd and Peripheral Arthritis
Not yet recruiting
- IBD-Inflammatory Bowel Disease
- (no location specified)
Jan 20, 2023
Ulcerative Colitis, Crohn Disease Trial in Surat (Vedolizumab IV)
Active, not recruiting
- Ulcerative Colitis
- Crohn Disease
- Vedolizumab IV
-
Guntur, Andhra Pradesh, India
- +17 more
Jan 26, 2023
Cutaneous Diphtheria in France : Observational, Retrospective
Not yet recruiting
- Corynebacterium Diphtheriae Infection
- Characteristics description
-
Toulon, VAR, FranceHIA Sainte Anne
Apr 3, 2023
Comorbidities and Pathologies Associated With Pyoderma
Unknown status
- Pyoderma Gangrenosum
- pathology associated
-
Marseille, Paca, FranceAssistance Publique Des Hopitaux de Marseille
Aug 17, 2018
Gliflozins on HF in Regurgitant Rheumatic Heart
Not yet recruiting
- Rheumatic Heart Disease
- Heart Failure
- SGLT2 inhibitor
- (no location specified)
Oct 27, 2023